Latest in Wegovy
Sort by
11 items
-
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.CBS News - Feb. 21 -
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.MarketWatch - Feb. 21 -
Ozempic and Wegovy officially moved off FDA's drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...The Hill - Feb. 21 -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - Feb. 21 -
Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy
Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight loss ...The Hill - 1d -
FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on ...CBS News - Feb. 22 -
In China you can get Ozempic and Wegovy within the hour for just $100 a month
Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of a button.MarketWatch - Feb. 25 -
There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers
Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.MarketWatch - 1d -
Novo Nordisk goes direct to consumer with Wegovy. What it means for obesity rival Eli Lilly
Shares of Eli Lilly rose Wednesday despite its rival's announcement.CNBC - 1d -
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.CNBC - 1d -
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insuranceABC News - 1d